Tearsheet
Investment Highlights Market Valuation Price Chart Return vs. Risk About COTY Interactive Breakdown Better Bets vs. COTY Latest Trefis Analyses Trade Ideas Recent Active Movers More From Trefis Peer Financials Peer Growth & Margins Peer Valuation Peer Returns Peer Analyses FDIC Bank Data Financials Segment Financials Price Behavior Short Interest Earnings Returns History SEC Filings Insider Activity Industry Resource Links External Quote Links

Coty (COTY)

Market Price (10/26/2025): $4.15 | Market Cap: $3.6 Bil
Sector: Consumer Staples | Industry: Personal Care Products

Coty (COTY)

Market Price (10/26/2025): $4.15
Market Cap: $3.6 Bil
Sector: Consumer Staples
Industry: Personal Care Products

Investment Highlights Why It Matters Which of these 2 stories sounds closer for this stock?

1. Generates cash flow

The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.

2. Riding a trend

Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow

0 Valuation becoming less expensive
P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is -31%		 Weak multi-year price returns
2Y Excs Rtn is -117%, 3Y Excs Rtn is -121%		 Debt is significant
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 110%
1 Attractive yield
FCF Yield is 7.7%		  Weak revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is -3.7%, Rev Chg QQuarterly Revenue Change % is -8.1%
2   Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -15%
0 Valuation becoming less expensive
P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is -31%
1 Attractive yield
FCF Yield is 7.7%
2 Weak multi-year price returns
2Y Excs Rtn is -117%, 3Y Excs Rtn is -121%
3 Debt is significant
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 110%
4 Weak revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is -3.7%, Rev Chg QQuarterly Revenue Change % is -8.1%
5 Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -15%

Market Valuation & Key Metrics

COTYS&P 500
REVENUE GROWTHVERY POOR
Rev LTM ($ Bil)5.9
Rev Chg Q-8.1%6.4%
Rev Chg LTM-3.7%5.3%
Rev Chg 3Y Avg3.7%5.4%
PROFITABILITYVERY POOR
Op Inc LTM ($ Bil)0.5
CFO LTM ($ Bil)0.5
Net Inc LTM ($ Bil)-0.4
Op Mgn LTM9.0%18.7%
CFO/Rev LTM8.4%20.4%
Net Inc Mgn-6.2%12.7%
VALUATIONVERY LOW
P/S0.63.3
P/CFO7.316.1
P/FCF13.020.9
P/E-9.824.0
STABILITYPOOR
Debt/Equity1.170.21
Cash/Assets0.020.07

COTY Stock

   
   
   
   
   
   
   

Return vs. Risk

Price Returns Compared

 202020212022202320242025Total [1]
Returns
COTY Return-37%50%-18%45%-44%-41%-63%
Peers Return30%7%-28%5%-33%-8%-34%
S&P 500 Return16%27%-19%24%23%15%110%

Monthly Win Rates [3]
COTY Win Rate33%67%50%50%17%22% 
Peers Win Rate52%52%40%43%45%38% 
S&P 500 Win Rate58%75%42%67%75%67% 

Max Drawdowns [4]
COTY Max Drawdown-76%-10%-43%0%-44%-47% 
Peers Max Drawdown-47%-14%-41%-28%-44%-35% 
S&P 500 Max Drawdown-31%-1%-25%-1%-2%-15% 

[1] Cumulative total returns since the beginning of 2020
[2] Peers: BRBR, EPC, HLF, NUS, MED. See COTY Returns vs. Peers.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 10/24/2025 (YTD)

How Low Can It Go

Unique KeyEventCOTYS&P 500
2022 Inflation Shock2022 Inflation Shock  
2022 Inflation Shock% Loss% Loss-45.3%-25.4%
2022 Inflation Shock% Gain to Breakeven% Gain to Breakeven83.0%34.1%
2022 Inflation ShockTime to BreakevenTime to Breakeven265 days464 days
2020 Covid Pandemic2020 Covid Pandemic  
2020 Covid Pandemic% Loss% Loss-78.2%-33.9%
2020 Covid Pandemic% Gain to Breakeven% Gain to Breakeven359.6%51.3%
2020 Covid PandemicTime to BreakevenTime to Breakeven926 days148 days
2018 Correction2018 Correction  
2018 Correction% Loss% Loss-71.6%-19.8%
2018 Correction% Gain to Breakeven% Gain to Breakeven252.4%24.7%
2018 CorrectionTime to BreakevenTime to BreakevenNot Fully Recovered days120 days

Compare to BRBR, EPC, HLF, NUS, MED


In The Past

Coty's stock fell -45.3% during the 2022 Inflation Shock from a high on 11/15/2021. A -45.3% loss requires a 83.0% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Coty (COTY)

Better Bets than Coty (COTY)

 COTYBetter Performance than COTY
MetricValueIndustry (Personal Care Products)
Rev Chg LTM-3.7%PG (1.2%), KVUE (-2.2%), ELF (18.6%)
Rev Chg 3Y Avg3.7%ELF (49.3%)
Op Mgn LTM9.0%PG (24.1%), KVUE (17.4%), ELF (11.6%)
CFO/Rev LTM8.4%PG (22.3%), EL (8.9%), KVUE (13.8%), ELF (11.9%)
FCF/Rev LTM4.7%PG (17.6%), KVUE (10.8%), ELF (10.1%)
Total Yield-10.2%PG (4.7%), EL (-3.1%), KVUE (10.4%), ELF (1.4%)
 COTYBetter Performance than COTY
MetricValueAll Other Sectors
Rev Chg LTM-3.7%NVDA (71.6%), AAPL (6.0%), MSFT (14.9%), GOOGL (13.1%), AMZN (10.9%)
Rev Chg 3Y Avg3.7%NVDA (92.0%), MSFT (12.5%), GOOGL (10.2%), AMZN (11.3%), META (13.0%)
Op Mgn LTM9.0%NVDA (58.1%), AAPL (31.9%), MSFT (45.6%), GOOGL (32.7%), AMZN (11.4%)
CFO/Rev LTM8.4%NVDA (46.6%), AAPL (26.6%), MSFT (48.3%), GOOGL (36.0%), AMZN (18.1%)
FCF/Rev LTM4.7%NVDA (43.6%), AAPL (23.5%), MSFT (25.4%), GOOGL (18.0%), META (30.7%)
Total Yield-10.2%NVDA (1.9%), AAPL (2.9%), MSFT (3.2%), GOOGL (4.0%), AMZN (3.0%)
 Best Bets In Consumer Staples Sector
 COTYMO PM MNST PG STZ CL HSY FIZZ SMPL KO
What You Pay           
P/E-9.812.428.443.221.320.121.723.818.114.123.0
P/EBIT-30.79.316.032.816.311.615.019.014.29.317.1
What You Get           
Rev Chg Q-8.1%0.2%9.4%11.1%3.0%-15.0%1.0%26.0%0.3%13.8%5.1%
Rev Chg LTM-3.7%-0.2%7.5%3.7%1.2%-5.6%0.1%2.5%0.5%14.2%2.8%
Rev Chg 3Y Avg3.7%-0.9%8.0%8.5%1.8%0.7%4.2%5.2%1.7%8.2%4.0%
FCF/Rev 3Y Avg6.0%42.7%24.9%21.4%18.0%17.0%15.4%13.9%13.9%13.8%13.9%

[1] Choosing top 10 best bets from each sector quarterly is an alpha producing strategy vs sector benchmark
[2] Historical annualized return of 8.7%, alpha of 1.4%, and sharpe of 0.5

Latest Trefis Analyses

TitleTopicDate
0DASHBOARDS  
1Coty Earnings Notes  
2How Low Can Coty Stock Really Go?Return 
3How Does Coty Stock Stack Up Against Its Peers?Peer Comparison 
4Better Bet Than COTY Stock: Pay Less Than Coty To Get More From UAL, IBKR   
5Better Bet Than COTY Stock: Pay Less Than Coty To Get More From CALM   
6Coty (COTY) Revenue ComparisonFinancials 
7Coty (COTY) Net Income ComparisonFinancials 
8Coty (COTY) EBITDA ComparisonFinancials 
9Coty (COTY) Operating Cash Flow ComparisonFinancials 
10Coty (COTY) Debt ComparisonFinancials 
11ARTICLES  
12What’s Next For Coty Stock After a 50% Drop? August 25th, 2025
13Market Movers | Winners: SSII, BLND, TYRA | Losers: COTY, NVAX, HOV August 21st, 2025
14Up 1.2x Last Week, Coty Stock Has Room For More Upside August 31st, 2021
15Demand Recovery Could Spur 15% Rise In Coty Stock May 26th, 2021
16Weak Demand Could See Coty Stock Drop 15% April 1st, 2021

Trade Ideas

Select past ideas related to COTY. For more, see Trefis Trade Ideas.

Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
IPAR_9302025_Dip_Buyer_FCFYield09302025IPARInterparfumsDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin		-1.9%-1.9%-6.0%
TAP_9302025_Dip_Buyer_FCFYield09302025TAPMolson Coors BeverageDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin		0.4%0.4%0.0%
STZ_7312025_Monopoly_xInd_xCD_Getting_Cheaper07312025STZConstellation BrandsMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		-16.4%-16.4%-21.1%
SJM_6302025_Dip_Buyer_FCFYield06302025SJMJM SmuckerDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin		5.0%5.0%0.0%
BF-B_5312025_Dip_Buyer_ValueBuy05312025BF-BBrown-FormanDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin		-14.8%-14.8%-22.4%
Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
IPAR_9302025_Dip_Buyer_FCFYield09302025IPARInterparfumsDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin		-1.9%-1.9%-6.0%
TAP_9302025_Dip_Buyer_FCFYield09302025TAPMolson Coors BeverageDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin		0.4%0.4%0.0%
STZ_7312025_Monopoly_xInd_xCD_Getting_Cheaper07312025STZConstellation BrandsMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple		-16.4%-16.4%-21.1%
SJM_6302025_Dip_Buyer_FCFYield06302025SJMJM SmuckerDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin		5.0%5.0%0.0%
BF-B_5312025_Dip_Buyer_ValueBuy05312025BF-BBrown-FormanDip BuyDB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin		-14.8%-14.8%-22.4%

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1VICRVicor57.5%87.2%
2INBXInhibrx Biosciences53.8%272.0%
3CLBCore Laboratories48.7%-2.4%
4BALYBallys46.2%6.8%
5MOFGMidWestOne Financial43.2%39.2%
6NUVBNuvation Bio42.2%82.3%
7CLOVClover Health Investments41.0%21.3%
8CELCCelcuity36.6%442.2%
9WGOWinnebago Industries33.6%-12.7%
10GTXGarrett Motion33.3%91.3%

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1PMIPicard Medical-45.4%8328.6%
2ITGRInteger-30.4%-45.0%
3METCRamaco Resources-23.8%244.9%
4WRLDWorld Acceptance-18.6%25.6%
5ASMAvino Silver & Gold Mines-18.2%450.5%
6SESSES AI-17.6%15.5%
7SMPLSimply Good Foods-17.5%-48.0%
8TNGXTango Therapeutics-17.0%142.6%
9OKLOOklo-16.7%540.8%
10LENZLENZ Therapeutics-16.4%10.7%

1 Month Top Gainers

#TickerCompany1M RtnYTD Rtn
1WOLFWolfspeed1498.4%344.0%
2PRAXPraxis Precision Medicines253.2%126.1%
3NVTSNavitas Semiconductor116.1%294.1%
4SNDKSanDisk97.4% 
5UAMYUnited States Antimony90.3%578.5%
6GRALGRAIL85.2%400.8%
7BALYBallys82.9%6.8%
8ORKAOruka Therapeutics81.1%40.5%
9INBXInhibrx Biosciences79.9%272.0%
10CIFRCipher Mining77.2%345.3%

1 Month Top Losers

#TickerCompany1M RtnYTD Rtn
1VGVenture Global-35.7% 
2PMIPicard Medical-35.3%8328.6%
3SOCSable Offshore-33.7%-41.7%
4FWRDForward Air-28.9%-39.0%
5FLYFirefly Aerospace-28.5% 
6ITGRInteger-28.4%-45.0%
7USNAUsana Health Sciences-26.5%-42.0%
8HTZHertz Global-26.3%41.5%
9RCReady Capital-25.1%-50.3%
10ULHUniversal Logistics-24.8%-61.0%

Recent Active Movers

1 Week Top Gainers

#TickerCompany1W RtnYTD Rtn
1VICRVicor57.5%87.2%
2INBXInhibrx Biosciences53.8%272.0%
3CLBCore Laboratories48.7%-2.4%
4BALYBallys46.2%6.8%
5MOFGMidWestOne Financial43.2%39.2%
6NUVBNuvation Bio42.2%82.3%
7CLOVClover Health Investments41.0%21.3%
8CELCCelcuity36.6%442.2%
9WGOWinnebago Industries33.6%-12.7%
10GTXGarrett Motion33.3%91.3%

1 Week Top Losers

#TickerCompany1W RtnYTD Rtn
1PMIPicard Medical-45.4%8328.6%
2ITGRInteger-30.4%-45.0%
3METCRamaco Resources-23.8%244.9%
4WRLDWorld Acceptance-18.6%25.6%
5ASMAvino Silver & Gold Mines-18.2%450.5%
6SESSES AI-17.6%15.5%
7SMPLSimply Good Foods-17.5%-48.0%
8TNGXTango Therapeutics-17.0%142.6%
9OKLOOklo-16.7%540.8%
10LENZLENZ Therapeutics-16.4%10.7%

More From Trefis

Research & Analysis

Invest in Strategies

Wealth Management

Peer Comparisons for Coty

Financials

COTYBRBREPCHLFNUSMEDMedian
NameCoty BellRing.Edgewell.HerbalifeNu Skin .Medifast  
Mkt Price4.1433.0519.698.3411.0212.5411.78
Mkt Cap3.64.20.90.90.50.10.9
Rev LTM5,8932,2242,2044,9281,6264802,214
Op Inc LTM531367208489570288
FCF LTM2781274317159-293
FCF 3Y Avg3501691161615684138
CFO LTM493132118265934125
CFO 3Y Avg57817217428710793173

Growth & Margins

COTYBRBREPCHLFNUSMEDMedian
NameCoty BellRing.Edgewell.HerbalifeNu Skin .Medifast  
Rev Chg LTM-3.7%16.3%-2.9%-2.2%-11.8%-37.6%-3.3%
Rev Chg 3Y Avg3.7%18.6%0.4%-3.4%-13.1%-33.0%-1.5%
Rev Chg Q-8.1%6.2%-3.2%-1.7%-12.1%-37.4%-5.7%
QoQ Delta Rev Chg LTM-1.8%1.5%-0.9%-0.4%-3.2%-11.6%-1.4%
Op Mgn LTM9.0%16.5%9.5%9.9%3.5%0.1%9.2%
Op Mgn 3Y Avg9.4%17.4%10.5%8.2%3.9%5.7%8.8%
QoQ Delta Op Mgn LTM-0.2%-3.3%-0.6%1.1%0.5%1.3%0.2%
CFO/Rev LTM8.4%5.9%5.4%5.4%5.7%0.9%5.6%
CFO/Rev 3Y Avg9.9%9.2%7.7%5.7%5.9%8.1%7.9%
FCF/Rev LTM4.7%5.7%1.9%3.5%3.6%-0.5%3.5%
FCF/Rev 3Y Avg6.0%9.1%5.1%3.2%3.2%7.0%5.6%

Valuation

COTYBRBREPCHLFNUSMEDMedian
NameCoty BellRing.Edgewell.HerbalifeNu Skin .Medifast  
Mkt Cap3.64.20.90.90.50.10.9
P/S0.61.90.40.20.30.30.4
P/EBIT-30.711.45.81.74.0283.04.9
P/E-9.818.314.22.65.437.99.8
P/CFO7.331.87.83.25.833.27.6
Total Yield-10.2%5.5%9.5%37.9%20.7%2.8%7.5%
Dividend Yield0.0%0.0%2.4%0.0%2.2%0.1%0.1%
FCF Yield 3Y Avg5.0%2.6%6.2%15.4%11.8%13.7%9.0%
D/E1.20.21.52.70.60.10.9
Net D/E1.10.21.32.40.1-1.10.7

Returns

COTYBRBREPCHLFNUSMEDMedian
NameCoty BellRing.Edgewell.HerbalifeNu Skin .Medifast  
1M Rtn5.3%-9.8%1.4%-4.7%-8.2%-8.1%-6.4%
3M Rtn-19.1%-39.6%-26.6%-14.5%26.6%-15.8%-17.5%
6M Rtn-16.7%-56.0%-35.3%25.0%93.3%1.6%-7.5%
12M Rtn-45.3%-48.7%-41.7%23.9%84.0%-28.0%-34.9%
3Y Rtn-37.7%38.6%-47.5%-61.6%-67.8%-88.4%-54.6%
1M Excs Rtn2.5%-12.6%-1.4%-7.5%-11.0%-11.0%-9.2%
3M Excs Rtn-25.9%-46.8%-30.6%-20.8%18.3%-20.0%-23.3%
6M Excs Rtn-39.6%-79.0%-58.3%2.1%70.4%-21.3%-30.5%
12M Excs Rtn-60.7%-65.6%-58.1%6.4%70.0%-43.5%-50.8%
3Y Excs Rtn-121.3%-28.7%-129.2%-144.0%-149.7%-172.1%-136.6%

Comparison Analyses

Financials

$ Mil | FY: 6/302025Q42025Q32025Q22025Q12024Q42024Q32024Q22024Q12023Q42023Q32023Q22023Q1
Period End6/30/20253/31/202512/31/20249/30/20246/30/20243/31/202412/31/20239/30/20236/30/20233/31/202312/31/20229/30/2022
Filing Date8/21/20255/7/20252/10/202511/6/20248/20/20245/7/20242/8/202411/8/20238/22/20235/9/20232/8/202311/8/2022
Key Financials Quarterly            
Total Revenue1,2521,2991,6701,6721,3631,3861,7281,6411,3521,2891,5241,390
Ebitda91-30521929861167424225261314449368
Operating Income149270238367924222612842196171
Net Income-69-4062483-974181233108238129
EPS-0.08-0.470.020.09-0.110.000.20-0.000.030.120.280.15
Key Financials TTM            
Total Revenue TTM5,8936,0046,0906,1486,1186,1066,0105,8065,5545,3715,2685,323
Ebitda TTM3022737459508771,0771,2241,2491,3931,0349571,009
Operating Income TTM531554623596583675638592537356367418
Net Income TTM-368-3961417189219324381508194139162
Growth Rates Quarterly            
Total Revenue Growth-8.1%-6.2%-3.3%1.8%0.9%7.5%13.4%18.1%15.7%8.7%-3.5%1.3%
EBITDA Growth48.0%-283.3%-48.4%32.5%-76.5%-47.0%-5.5%-39.0%366.1%32.2%-10.3%-32.3%
Operating Income Growth-62.9%-88.6%11.2%5.6%-71.5%86.5%23.4%32.3%339.1%-21.3%-20.4%408.0%
Net Income Growth29.0%-10776.3%-86.9%5081.2%-394.5%-96.5%-24.1%-98.8%111.7%102.2%-8.8%-43.1%
Margins Quarterly            
EBITDA Margin7.3%-23.5%13.1%17.8%4.5%12.0%24.6%13.7%19.3%24.4%29.5%26.5%
Operating Income Margin1.1%0.7%16.1%14.3%2.7%5.7%14.0%13.8%9.5%3.3%12.9%12.3%
Net Income Margin-5.5%-31.2%1.4%5.0%-7.1%0.3%10.5%0.1%2.4%8.4%15.6%9.3%
Cash & Debt            
Total Cash257244250284301260450280247245281216
Total Debt4,2454,0893,6614,2244,1214,1984,0054,4404,5494,6094,4084,670
Net Debt / (Cash)3,9883,8453,4113,9413,8203,9383,5554,1604,3024,3644,1284,454
Cash Flows Quarterly            
FCF from Operations83-12246467176-170422186105-125482163
Cash Flows TTM            
FCF from Operations TTM493586538496615543588649626488637604
Returns to Shareholders Quarterly            
Dividends333033403344
Share Repurchases-0-0-0-0-0-0-0-0-0-0-0-0
Return on Invested Capital (ROIC) Quarterly            
ROIC0.5%0.3%5.6%5.8%1.2%2.8%6.1%1.6%2.0%1.1%5.9%3.9%
Return on Invested Capital (ROIC) TTM            
ROIC TTM4.8%5.1%2.4%3.5%2.9%3.8%3.6%3.7%3.4%1.8%1.8%2.1%

Price Behavior

COTY Betas & Captures as of 9/30/2025

 1M2M3M6M1Y3Y
Beta0.362.152.221.311.071.19
Up Beta7.741.541.241.351.301.46
Down Beta0.361.422.490.720.640.85
Up Capture-115%129%163%131%45%81%
Bmk +ve Days13233574144420
Stock +ve Days8172656109365
Down Capture-56%399%353%192%134%106%
Bmk -ve Days8192952107330
Stock -ve Days12243668137369

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively

Short Interest

Short Interest: As Of Date10152025
Short Interest: Shares Quantity23,571,816
Short Interest: % Change Since 93020254.2%
Average Daily Volume6,544,910
Days-to-Cover Short Interest3.60
Basic Shares Quantity872,400,000
Short % of Basic Shares2.7%

Returns Analyses

Earnings Returns History

Expand for More

 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
8/20/2025-21.6%-13.6%-15.4%
5/6/2025-11.6%-1.7%-5.4%
2/10/2025-9.3%-16.5%-18.5%
11/6/2024-2.4%-0.7%2.4%
8/20/20246.3%0.2%-1.5%
5/6/2024-3.5%-2.9%-12.1%
2/7/2024-2.5%-4.6%4.5%
11/7/20231.2%9.1%17.7%
...
SUMMARY STATS   
# Positive111312
# Negative131112
Median Positive10.6%8.3%8.0%
Median Negative-7.4%-9.6%-7.1%
Max Positive22.2%32.6%123.1%
Max Negative-21.6%-28.5%-18.5%

SEC Filings

Expand for More

Report DateFiling DateFiling
6302025821202510-K 6/30/2025
3312025507202510-Q 3/31/2025
12312024210202510-Q 12/31/2024
93020241106202410-Q 9/30/2024
6302024820202410-K 6/30/2024
3312024507202410-Q 3/31/2024
12312023208202410-Q 12/31/2023
93020231108202310-Q 9/30/2023
6302023822202310-K 6/30/2023
3312023509202310-Q 3/31/2023
12312022208202310-Q 12/31/2022
93020221108202210-Q 9/30/2022
6302022825202210-K 6/30/2022
3312022509202210-Q 3/31/2022
12312021208202210-Q 12/31/2021
93020211108202110-Q 9/30/2021

Insider Activity

Expand for More

 OwnerTitleFiling DateActionPriceSharesTransacted
Value		Value of
Held Shares		Form
0Blazewicz KristinChief Legal Officer9032025Buy4.3029,400126,5323,568,461Form
1Mercier LaurentChief Financial Officer8282025Buy3.9612,50049,5001,592,775Form
2Srinivasan PriyaChief People & Purpose Officer8262025Buy3.8430,000115,200144,035Form
3Nabi SueChief Executive Officer8262025Buy3.92260,0001,018,160125,810,452Form

External Quote Links


Prefer one of these to Trefis? Tell us why.